On December 2, 2024, John Daly, Director at CareCloud Inc (CCLD, Financial), sold 10,000 shares of the company, according to a SEC Filing. Following this transaction, the insider now owns 66,750 shares of the company. CareCloud Inc (CCLD) is a healthcare technology company that provides cloud-based solutions and services to healthcare providers. The company offers a comprehensive suite of products, including electronic health records, practice management, revenue cycle management, and telehealth solutions, aimed at improving the efficiency and effectiveness of healthcare delivery. The insider transaction history for CareCloud Inc shows that there have been three insider buys and one insider sell over the past year. Over the same period, John Daly has sold a total of 10,000 shares and purchased zero shares.
On the day of the recent sale, shares of CareCloud Inc were trading at $3.65 each, giving the stock a market cap of $56.839 million. The stock's GF Value is estimated at $2.42, resulting in a price-to-GF-Value ratio of 1.51. This indicates that the stock is significantly overvalued based on its GF Value. The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on three factors: - Historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow that the stock has traded at. - A GuruFocus adjustment factor based on the company’s past returns and growth. - Future estimates of business performance from Morningstar analysts.This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.